DK1567137T3 - Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner - Google Patents

Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner

Info

Publication number
DK1567137T3
DK1567137T3 DK03772659T DK03772659T DK1567137T3 DK 1567137 T3 DK1567137 T3 DK 1567137T3 DK 03772659 T DK03772659 T DK 03772659T DK 03772659 T DK03772659 T DK 03772659T DK 1567137 T3 DK1567137 T3 DK 1567137T3
Authority
DK
Denmark
Prior art keywords
resveratrol
manufacture
treatment
influenza virus
virus infections
Prior art date
Application number
DK03772659T
Other languages
English (en)
Inventor
Enrico Garaci
Anna T Palamara
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1567137T3 publication Critical patent/DK1567137T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03772659T 2002-11-06 2003-10-14 Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner DK1567137T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
PCT/IT2003/000626 WO2004041260A1 (en) 2002-11-06 2003-10-14 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections

Publications (1)

Publication Number Publication Date
DK1567137T3 true DK1567137T3 (da) 2008-04-28

Family

ID=32310188

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03772659T DK1567137T3 (da) 2002-11-06 2003-10-14 Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner

Country Status (18)

Country Link
US (1) US8431617B2 (da)
EP (1) EP1567137B1 (da)
JP (1) JP4589118B2 (da)
KR (1) KR101060331B1 (da)
AR (1) AR041891A1 (da)
AT (1) ATE381929T1 (da)
AU (1) AU2003279551A1 (da)
CA (1) CA2504872C (da)
CY (1) CY1107302T1 (da)
DE (1) DE60318327T2 (da)
DK (1) DK1567137T3 (da)
ES (1) ES2295660T3 (da)
IT (1) ITRM20020562A1 (da)
MX (1) MXPA05004628A (da)
PL (1) PL217628B1 (da)
PT (1) PT1567137E (da)
TW (1) TWI337863B (da)
WO (1) WO2004041260A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009515933A (ja) * 2005-11-18 2009-04-16 アレス トレーディング ソシエテ アノニム インフルエンザにおけるインターフェロン
WO2009136979A2 (en) * 2008-03-06 2009-11-12 Mount Sinai School Of Medicine Of New York University Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
AU2009313657A1 (en) * 2008-11-04 2010-05-14 Metaproteomics, Llc Phytochemical compositions and methods for activating AMP-kinase
CA2744947A1 (en) * 2008-12-19 2010-10-28 The Regents Of The University Of California Use of epidermal growth factor inhibitors in the treatment of viral infection
KR100950445B1 (ko) 2009-10-26 2010-04-02 주식회사 중앙백신연구소 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
US9096585B2 (en) 2010-05-28 2015-08-04 Icahn School Of Medicine At Mount Sinai Antiviral compounds and uses thereof
US9453017B2 (en) * 2011-09-30 2016-09-27 Vanderbilt University Antiviral therapies with phospholipase D inhibitors
PL2952180T3 (pl) 2014-06-04 2017-05-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. STAŁE FORMULACJE ZAWIERAJĄCE RESWERATROL I WIELONIENASYCONE KWASY TŁUSZCZOWE OMEGA-3 (n-3 PUFA)
EP2952209B1 (en) 2014-06-04 2018-03-28 Alfasigma S.p.A. Homogeneous formulations comprising omega-3 polyunsaturated fatty acids (n-3 PUFA) and resveratrol for oral administration
EP3120842A1 (en) 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid
KR20170039456A (ko) 2015-10-01 2017-04-11 동아대학교 산학협력단 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) * 2016-08-09 2018-02-15 株式会社ブレインヘルス 抗生物質含有組成物
CN108893558B (zh) * 2018-05-24 2022-04-05 江苏海宏制药有限公司 一种桑木液原液抗病毒实验方法以及装置
WO2021207094A1 (en) * 2020-04-05 2021-10-14 Mong Michael Systems and methods for treating coronavirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
PE20010540A1 (es) * 1999-07-30 2001-05-15 Procter & Gamble Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
WO2001012228A2 (en) * 1999-08-13 2001-02-22 University Of Maryland Biotechnology Institute Compositions for treating viral infections, and methods therefor

Also Published As

Publication number Publication date
ATE381929T1 (de) 2008-01-15
PL217628B1 (pl) 2014-08-29
PL377557A1 (pl) 2006-02-06
EP1567137A1 (en) 2005-08-31
TWI337863B (en) 2011-03-01
AU2003279551A1 (en) 2004-06-07
TW200501935A (en) 2005-01-16
DE60318327T2 (de) 2008-12-18
WO2004041260A1 (en) 2004-05-21
EP1567137B1 (en) 2007-12-26
AR041891A1 (es) 2005-06-01
KR20050071627A (ko) 2005-07-07
ITRM20020562A1 (it) 2004-05-07
KR101060331B1 (ko) 2011-08-30
JP2006507295A (ja) 2006-03-02
CA2504872A1 (en) 2004-05-21
JP4589118B2 (ja) 2010-12-01
DE60318327D1 (de) 2008-02-07
ES2295660T3 (es) 2008-04-16
PT1567137E (pt) 2008-02-19
CA2504872C (en) 2011-07-05
MXPA05004628A (es) 2005-09-08
US8431617B2 (en) 2013-04-30
US20050239906A1 (en) 2005-10-27
CY1107302T1 (el) 2012-11-21

Similar Documents

Publication Publication Date Title
DK1542748T3 (da) Engangssprøjte
IS7894A (is) Skammtaform með ofnæmisvaka
DK1545662T3 (da) Lægemiddelindgivelsessystem
DE602004018587D1 (de) Staubschützende Wegwerfmaske
DK1633726T3 (da) Pyrimidinderivater, der er egnede til behandling af CRTH2-formidlede sygdomme
NO20054608D0 (no) Influensavirusvaksine
NO20052058D0 (no) Behandling av influensa.
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK1567137T3 (da) Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
DK1601359T3 (da) Væskeformige, farmaceutiske formuleringer af palonosetron
NO20044322L (no) Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament
DK2388315T3 (da) Anvendelse af et myxomvirus, som ikke eksprimerer funktionelt M135R, til terapeutisk behandling
DE602004012448D1 (de) Morpholinylhaltige benzimidazole als inhibitoren der replikation von respiratory syncytial virus
DK1709075T3 (da) Behandling af virusinfektioner
CL2004000261A1 (es) Procedimiento para la eliminacion de virus en soluciones de fibrinogeno de aplicacion terapeutica.
ES1053382Y (es) Protesis dilatadora del vestibulo nasal.
DK1494650T3 (da) Farmaceutisk formulering, der indeholder melatonin
DK1541137T3 (da) Transdermalt delivery system af gestoden
DE112004000806D2 (de) Phenol urea/melamineformaldehydecopolymers, method for the production thereof and use of the same
DE50212677D1 (de) Unidirektionales zählwerk
DK1446131T3 (da) Anvendelse af specifik dosis af fondaparinux-natrium til behandling af ACS
DK1684868T3 (da) Bekæmpelse af HIV-infektioner med menneskeligt blodplasma, der er oxideret med hypochlorsyrling
DK1653963T3 (da) Nasal farmaceutisk sammensætning piribedil
DK1474415T3 (da) 1-phenyl-2-heteroaryl-substituerede benzimidazolderivater, deres anvendelse til fremstilling af lægemidler til behandling af immunologiske sygdomme